Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
Leary
S E
SE
Chemical and Biological Defence Establishment, Porton Down, Salisbury, Wiltshire, UK.
Eley
S M
SM
Williamson
E D
ED
Titball
R W
RW
D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics*; D003001:Cloning, Molecular; D005260:Female; D005798:Genes, Bacterial; D006801:Humans; D051379:Mice; D010930:Plague / Q000276:immunology / Q000517:prevention & control*; D010931:Plague Vaccine / Q000235:genetics / Q000302:isolation & purification*; D052899:Pore Forming Cytotoxic Proteins; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics; D014614:Vaccines, Synthetic / Q000235:genetics / Q000302:isolation & purification; D015010:Yersinia pestis / Q000235:genetics* / Q000276:immunology*
D000942:Antigens, Bacterial; C043908:LcrV protein, Yersinia; D010931:Plague Vaccine; D052899:Pore Forming Cytotoxic Proteins; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic